IRIS
NOVI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.230
Totale 2.230
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.230
Totale 2.230
Salva come PNG Salva come JPEG
Città #
Genova 1.177
Genoa 416
Rapallo 329
Vado Ligure 304
Bordighera 4
Totale 2.230
Salva come PNG Salva come JPEG
Nome #
Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register 144
Different MRI patterns in MS worsening after stopping fingolimod 140
The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms 124
Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. 120
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 120
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 117
Tocilizumab in MOG-antibody spectrum disorder: a case report 108
Ghost spasticity in multiple sclerosis 108
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders 103
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 102
Longitudinal brain magnetic resonance imaging and real-time quaking induced conversion analysis in presymptomatic Creutzfeldt-Jakob disease 101
Acute disseminated encephalomyelitis after SARS-CoV-2 infection 96
Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. 89
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 86
Erythropoietin therapy in a case of neonatal anemia after exposure to natalizumab throughout pregnancy 74
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 74
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 69
Assessing upper limb function in Multiple Sclerosis by an engineered glove 67
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? 58
Interleukin-6 Receptor Blockade in Treatment- Refractory MOG-Ab–Associated Disease and Neuromyelitis Optica Spectrum Disorders 55
Fulminant Hepatitis Associated with Echovirus 25 during Treatment with Ocrelizumab for Multiple Sclerosis 54
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 50
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 48
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 42
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 41
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 36
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 35
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 21
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 14
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 8
Relapsing meningitis and limbic encephalitis in anti-AQP4-Ab-associated neuromyelitis optica spectrum disorder 7
Totale 2.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.203
article - articoli 9.925
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.128
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020299 0 0 0 0 0 0 64 43 65 74 41 12
2020/2021279 18 16 22 53 37 15 19 21 18 31 16 13
2021/2022297 11 7 12 24 17 20 12 67 16 38 29 44
2022/2023396 38 38 8 48 42 63 2 23 66 4 57 7
2023/2024315 14 26 3 36 20 68 57 13 16 18 10 34
2024/2025359 59 49 18 57 97 76 3 0 0 0 0 0
Totale 2.311